title: Metoprolol-induced Total Body Erythroderma.
authors.affiliation: Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. jbdoyon@partners.org.
authors.forename: Jeffrey B
authors.initials: JB
authors.lastname: Doyon
authors.affiliation: Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA.
authors.forename: Kristina J
authors.initials: KJ
authors.lastname: Liu
authors.affiliation: Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
authors.forename: Rebecca A
authors.initials: RA
authors.lastname: Berman
mesh_terms: D058671:Adrenergic beta-1 Receptor Antagonists / Q000009:adverse effects*; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D003873:Dermatitis, Exfoliative / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D005260:Female; D006801:Humans; D008790:Metoprolol / Q000009:adverse effects*; D011565:Psoriasis / Q000150:complications
chemical_list: D058671:Adrenergic beta-1 Receptor Antagonists; D000889:Anti-Arrhythmia Agents; D008790:Metoprolol
keywords: beta-blocker; drug reaction; erythroderma; psoriasis